IGMS(Delisted)

IGM Biosciences·NASDAQ

--(--)

IGM Biosciences (IGMS) Company Profile

Igm Biosciences, Inc.

A clinical-stage biotech company focused on creating and developing IgM antibodies

Industry

Established Date

Listing Date

09/18/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

149

Fiscal Year Ends

12-31

Website

www.igmbio.com

Security Type

Common stock

Office address

325 E. Middlefield Road, Mountain View, CA 94043

Business

Introduction

IGM Biosciences, Inc., was incorporated in Delaware in August 1993 under the name Palingen, Inc. IGM Biosciences, Inc., is a biotechnology company developing IgM antibody therapies for the treatment of cancer.